Advanced search
Publication Cover
Future Science OA Volume 2, 2016 - Issue 4
Submit an article Journal homepage
1,556
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of a Novel ELISA for the Tumor-Associated Antigen CA 72–4 in Patients with Ovarian Cancer

Paul Buderath1 Department of Obstetrics & Gynecology, University Hospital Essen, Hufelandstr. 55, 45147Essen, GermanyCorrespondence[email protected]
,
Sabine Kasimir-Bauer1 Department of Obstetrics & Gynecology, University Hospital Essen, Hufelandstr. 55, 45147Essen, Germany
,
Bahriye Aktas1 Department of Obstetrics & Gynecology, University Hospital Essen, Hufelandstr. 55, 45147Essen, Germany
,
Jens Rasch1 Department of Obstetrics & Gynecology, University Hospital Essen, Hufelandstr. 55, 45147Essen, Germany
,
Rainer Kimmig1 Department of Obstetrics & Gynecology, University Hospital Essen, Hufelandstr. 55, 45147Essen, Germany
,
Thomas Zeller1 Department of Obstetrics & Gynecology, University Hospital Essen, Hufelandstr. 55, 45147Essen, Germany;2 DRG Instruments GmbH, Frauenbergstraße 18, 35039Marburg, Germany
&
Martin Heubner1 Department of Obstetrics & Gynecology, University Hospital Essen, Hufelandstr. 55, 45147Essen, Germany
 show all
Article: FSO145 | Accepted 01 Aug 2016, Published online: 12 Oct 2016

References

  • Colcher D, Hand PH, Nuti M, Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc. Natl Acad. Sci. USA 78(5), 3199–3203 (1981).
  • Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res. 46(2), 850–857 (1986).
  • Gero EJ, Colcher D, Ferroni P et al. CA 72–4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients. J. Clin. Lab. Anal. 3(6), 360–369 (1989).
  • Thor A, Gorstein F, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. J. Natl Cancer Inst. 76(6), 995–1006 (1986).
  • Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 46(6), 3118–3124 (1986).
  • Thor A, Viglione MJ, Muraro R, Ohuchi N, Schlom J, Gorstein F. Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues. Int. J. Gynecol. Pathol. 6(3), 235–247 (1987).
  • Ohuchi NGE, Mort S, Akimoto M et al. Clinical evaluation of CA 72 -4 immunoradiometric assay for serum TAG-72 antigen in patients with carcinoma. J. Tumor Marker Oncol. 5(1990), 1–10 (1990).
  • Zeimet AG, Guadagni F, Marth C et al. [Value of the TAG-72 (CA 72–4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker]. Geburtshilfe Frauenheilkd. 55(4), 195–199 (1995).
  • Schutter EM, Sohn C, Kristen P et al. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72–4 in postmenopausal women with a pelvic mass: an international multicenter study. Gynecol. Oncol. 69(1), 56–63 (1998).
  • Granato T, Midulla C, Longo F, Colaprisca B, Frati L, Anastasi E. Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer. Tumour Biol. 33(5), 1335–1339 (2012).
  • Bian J, Li B, Kou XJ, Liu TZ, Ming L. Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer. Asian Pac. J. Cancer Prev. 14(11), 6241–6243 (2013).
  • Terry KL, Schock H, Fortner RT et al. A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort. Clin. Cancer Res. pii: clincanres.0316.2016 (2016) ( Epub ahead of print).
  • Anastasi E, Manganaro L, Granato T, Benedetti Panici P, Frati L, Porpora MG. Is CA72–4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer? Dis. Mark. 35(5), 331–335 (2013).
  • Fayed ST, Ahmad SM, Kassim SK, Khalifa A. The value of CA 125 and CA72–4 in management of patients with epithelial ovarian cancer. Dis. Mark. 14(3), 155–160 (1998).
  • DRG Diagnostics. CA 72-4 CLIA User’s Manual. http://www.drg-diagnostics.de/files/cla-4730_ifu--ca-72-4_2009-04-28_en_v1.0.pdf

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.